Quest Diagnostics
Quest Diagnostics Incorporated, a leading provider in the diagnostic testing industry, is headquartered in the United States. Founded in 1967, the company has established itself as a pivotal player in laboratory services, offering a comprehensive range of diagnostic information services that include clinical laboratory testing, anatomic pathology, and genetic testing. With a strong operational presence across North America, Quest Diagnostics is renowned for its commitment to innovation and quality, providing unique solutions that enhance patient care. The company has achieved significant milestones, including advancements in molecular diagnostics and a robust network of patient service centres. Recognised for its market leadership, Quest Diagnostics continues to set the standard in the healthcare sector, delivering reliable and accurate testing services that empower healthcare providers and patients alike.
DitchCarbon Score
How does Quest Diagnostics's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Quest Diagnostics's score of 27 is higher than 81% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Quest Diagnostics's reported carbon emissions
In 2022, Quest Diagnostics reported significant carbon emissions, with Scope 1 emissions totalling approximately 288,624,000 kg CO2e and Scope 2 emissions at about 104,080,000 kg CO2e in the US. Globally, their Scope 1 emissions reached around 107,228,000 kg CO2e, while Scope 2 emissions were approximately 91,613,000 kg CO2e. The company has not disclosed specific reduction targets or initiatives, indicating a lack of formal commitments to reduce emissions through frameworks such as the Science Based Targets initiative (SBTi). Historically, Quest Diagnostics has shown a trend in emissions reporting, with Scope 1 and 2 emissions data available from previous years. For instance, in 2021, their global Scope 1 emissions were about 238,910,000 kg CO2e, and Scope 2 emissions were approximately 107,948,000 kg CO2e. The company has not set documented reduction targets, which may reflect broader industry challenges in addressing climate change. Overall, while Quest Diagnostics has made strides in emissions reporting, the absence of specific reduction commitments highlights an area for potential improvement in their climate strategy.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2015 | 2016 | 2021 | 2022 | |
|---|---|---|---|---|
| Scope 1 | 83,929,000 | 00,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 145,724,000 | 000,000,000 | 000,000,000 | 00,000,000 |
| Scope 3 | 41,299,000 | 00,000,000 | 000,000,000 | 000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Quest Diagnostics is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
